The largest database of trusted experimental protocols

Complete mini protease inhibitor tablet

Manufactured by Merck Group
Sourced in United States

The Complete mini protease inhibitor tablet is a laboratory product designed to inhibit protease activity. It is intended for use in research applications to help maintain the integrity of protein samples during extraction and analysis.

Automatically generated - may contain errors

4 protocols using complete mini protease inhibitor tablet

1

Transient Expression of Jag1 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat FL-Jag1-HA (pBOS-SN3T), Jag1-CTF-HA (pEF6/V5-His) and JICD-HA (pEF6/V5-His) HA-tagged expression plasmids were provided by Matthew LaVoie (LaVoie and Selkoe, 2003 (link)) and verified using Sanger DNA sequencing. Each plasmid was transfected into B3 cells using the Fugene6 (Promega, Cat#:E2691) protocol at a 3:1 volume ratio of Fugene6 transfection reagent relative to that of the DNA. For immunocytochemistry experiments, 2.0×105 to 2.5×105 B3 cells were plated per well of a 2-well chamber slide (Thermo Fisher Scientific, Cat#:177429) and transfected with 40 ng of plasmid after 24 h (∼60–70% confluency). In experiments generating material for western blot analysis, 1.0×106 to 1.5×106 B3 cells were plated onto a 100 mm tissue culture plate and transfected with 5 µg of plasmid after 24 h (60–70% confluency). Cells remained in transfection mix media for 48 h at 37°C and 5% CO2 before either fixing for staining protocol or harvesting for protein extraction via cell-scraping in cold PBS plus cOmplete mini protease inhibitor tablet (Sigma-Aldrich, Cat#:11836153001), spinning briefly, and snap-freezing the cell pellet.
+ Open protocol
+ Expand
2

Measuring Cytochrome C Release from Mitochondria

Check if the same lab product or an alternative is used in the 5 most similar protocols
Release of cytochrome c from the mitochondria was measured by immunoblotting as previously described [31 (link)]. Cells were incubated with or without 100 nM crizotinib, 50uM chloroquine, or 100 nM crizotinib + 50 uM chloroquine for 6 hours. The cells were then obtained by scraping followed by gentle centrifugation at 1700rpm for 3 minutes. The pellets were then washed with cold PBS and re-spun for 3 minutes. Next the cells were lysed in an ice-cold buffer containing 250 mM Sucrose, 1 mM EDTA, 25 mM Tris, pH 6.8, 0.05% IGEPAL and a Complete Mini protease inhibitor tablet (Sigma-Aldrich) until the cells outer membrane was compromised as determined by the trypan blue exclusion assay. The cells were then centrifuged at 14,000 rpm for 5 min at 4 °C and the supernatant, containing the cytosolic fraction, was transferred to new tubes. The pellet containing the mitochondrial fraction was then suspended in lysis buffer, and cytochrome c was measured in each fraction by immunoblotting.
+ Open protocol
+ Expand
3

Ang-(1-7) and Ang II Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ang-(1–7) and Ang II were purchased from AnaSpec (Fremont, CA, USA). [Asn1 Val5]-Ang II was purchased from Sigma Aldrich (St. Louis, MO, USA) and used as LC–MS/MS assay internal standard (IS). Complete Mini™ protease inhibitor tablets were purchased from Sigma Aldrich (St. Louis, MO, USA). All solvents were LC–MS grade and were purchased from Sigma Chemical Co. The C18 solid-phase extraction (SPE) cartridges (3 mL, 500 mg) were obtained from Waters Corporation (Milford, MA, USA). Human recombinant ACE2 was purchased from Abcam (ab151852, Cambridge, United Kingdom). Double-distilled deionized water was used in all experiments.
+ Open protocol
+ Expand
4

CRH-Induced N2A Cell Proteomic Changes

Check if the same lab product or an alternative is used in the 5 most similar protocols
N2A cells were maintained in Dulbecco’s modified Eagle’s medium (invitrogen) supplemented with 10% fetal bovine serum (FBS). For experiments, equal numbers of cells (100 000 cells per well) were plated down in 6-well plates. Wells were treated 24 h later by removal of media and replacing with 2 mL of fresh media containing CRH (Bachem, Torrance, CA, USA) at a final concentration of 10 and 50 nM. Control wells contained fresh media only. After a treatment period of 5 h, cell lysates were collected using M-per (Thermo Fisher Scientific) extraction buffer (150 mg/mL), complemented with proteases inhibitor (Complete Mini Protease Inhibitor Tablets) and phosphatases inhibitor (5 mmol/L, Sigma-Aldrich), followed by centrifugation at 100 000 g for 1 h. Protein concentration in the supernatant was determined using the Bradford assay.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!